Tessenderlo Group is paying $13.30 per share for its new position, representing a 16% premium over FMC’s Tuesday closing price of $11.50. Investors responded immediately to the announcement, pushing FMC shares up 7.4% to $12.35 before the opening bell.
For FMC, the capital infusion provides the necessary liquidity to meet its $1 billion debt-reduction target. By finalizing this agreement, the company effectively concludes the broader strategic evaluation it initiated months ago to stabilize its balance sheet.
Comments (0)
No comments yet. Be the first!